Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Tapeworm Freedom
Controls must be maintained to keep UK tapeworm free.

The European Union and UK Veterinary Profession are in agreement that controls for tapeworm (Echinoccus Multicularis (EM) need to be maintained.  Consequently, the European Commission has formed a regulation that will permit pre-movement treatment for dogs travelling between the UK, Ireland, Finland and Malta.

Despite Defra’s changes to European pet travel rules, which adds further protection against rabies, ticks and tapeworms, there is still a significant public health risk regarding EM tapeworms.  As BVA President Harvey Locke, explains:

“In our role as guardians of public health, vets were deeply concerned that the removal of tapeworm controls would see the introduction of EM tapeworm to the UK and Ireland.  Although relatively benign in dogs, the resulting disease in humans – alveolar echinococcosis – is an invasive, cancer-lie cystic stage of the parasite, and is invariably fatal if not treated.”

Thus, the BVA and BSAVA have been working with Defra to urge the European Commission to focus on controls specifically aimed at controlling tapeworms.   The commission’s regulation ensures that dogs must be treated by a veterinary surgeon 24 – 120 hours (1-5 days) before entering the partnered countries.   The BVA did stress there was scientific support that the window for treatment need only be 24-48 hours, but they accepted the commission's compromise as it does prevent pet owners from getting treatment at the last minute.

Both the BVA and BSAVA were ‘delighted’ that the European Commission had reached a stable resolution.  Andrew Ash, President of BSAVA stated they will continue to follow this issue, and gave an important reminder to pet owners:

“The BVA and BSAVA will continue to promote the best possible health and welfare advice for pet owners taking their animals abroad.  Our advice to owners is to speak to a vet as early as possible to make sure pets are protected from all diseases and parasites encountered abroad.”

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.